AMN Healthcare Services Inc

AMN remains in a Stage 2 advance with clear higher highs and rising EMAs supported by an active Parabola, but price is extended above short-term EMAs and in extreme overbought territory. Medium-term bias stays bullish, anchored by trend acceleration, while the long-term trend remains down. Short-term timing is unfavorable for new entries; defer execution and stalk pullbacks into the rising EMA zone for a better risk–reward.

• ↑Q1 revenue $1.38B (+53% YoY), exceeded guidance by $122M, led by $722M labor disruption events
• ↑AI integration via AMN Passport raises fill rates and operational efficiency
• ↓Q1 gross margin 26.8% (-190 bps YoY), profitability score remains negative